Premium
CytoDyn Inc (QB) (CYDY)
USOTC
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0192 | -14.2222222222 | 0.135 | 0.135 | 0.112 | 2515205 | 0.11907906 | CS |
| 4 | 0.0003 | 0.25974025974 | 0.1155 | 0.15 | 0.1031 | 2331302 | 0.12231201 | CS |
| 12 | -0.0323 | -21.8095881161 | 0.1481 | 0.1599 | 0.1031 | 2632860 | 0.13040162 | CS |
| 26 | -0.0241 | -17.2265904217 | 0.1399 | 0.209 | 0.1031 | 2356744 | 0.13620339 | CS |
| 52 | -0.0917 | -44.1927710843 | 0.2075 | 0.315 | 0.1031 | 2553582 | 0.15961747 | CS |
| 156 | -0.9742 | -89.376146789 | 1.09 | 1.3 | 0.1031 | 2214270 | 0.31801993 | CS |
| 260 | -0.524 | -81.9005939356 | 0.6398 | 10.01 | 0.1031 | 3109886 | 2.01107087 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
